167 related articles for article (PubMed ID: 7584665)
1. Characterization of a domain of a human type I interferon receptor protein involved in ligand binding.
Eid P; Tovey MG
J Interferon Cytokine Res; 1995 Mar; 15(3):205-11. PubMed ID: 7584665
[TBL] [Abstract][Full Text] [Related]
2. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
3. Mapping of IFN-beta epitopes important for receptor binding and biologic activation: comparison of results achieved using antibody-based methods and alanine substitution mutagenesis.
Runkel L; De Dios C; Karpusas M; Baker D; Li Z; Zafari M; Betzenhauser M; Muldowney C; Miller S; Redlich PN; Grossberg SE; Whitty A; Hochman PS
J Interferon Cytokine Res; 2001 Nov; 21(11):931-41. PubMed ID: 11747625
[TBL] [Abstract][Full Text] [Related]
4. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor.
Benoit P; Maguire D; Plavec I; Kocher H; Tovey M; Meyer F
J Immunol; 1993 Feb; 150(3):707-16. PubMed ID: 8423335
[TBL] [Abstract][Full Text] [Related]
6. Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.
Cebrián M; Yagüe E; de Landázuri MO; Rodíguez-Moya M; Fresno M; Pezzi N; Llamazares S; Sánchez-Madrid F
J Immunol; 1987 Jan; 138(2):484-90. PubMed ID: 2432126
[TBL] [Abstract][Full Text] [Related]
7. Human interferon-gamma receptor. Mapping of epitopes recognized by neutralizing antibodies using native and recombinant receptor proteins.
Garotta G; Ozmen L; Fountoulakis M; Dembic Z; van Loon AP; Stüber D
J Biol Chem; 1990 Apr; 265(12):6908-15. PubMed ID: 1691178
[TBL] [Abstract][Full Text] [Related]
8. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of interferon-alpha subtypes using monoclonal antibodies to interferon-alpha 4a--subtype reactivity, neutralisation of biological activities and epitope analysis.
Overall ML; Hertzog PJ
Mol Immunol; 1992 Mar; 29(3):391-9. PubMed ID: 1372957
[TBL] [Abstract][Full Text] [Related]
10. Epitopes of human interferon-alpha defined by the reaction of monoclonal antibodies with alpha interferons and interferon analogues.
Taylor-Papadimitriou J; Shearer M; Griffin D
J Immunol; 1987 Nov; 139(10):3375-81. PubMed ID: 2445813
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody to the NH2-terminal region of human interferon-gamma inhibits its antiproliferative activity without affecting its internalization.
Folghera S; Caruso A; Fiorentini S; Rusnati M; Gao J; Gargiulo F; Balsari A; Turano A
J Interferon Cytokine Res; 1995 Mar; 15(3):197-204. PubMed ID: 7584664
[TBL] [Abstract][Full Text] [Related]
12. Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein.
Ling LE; Zafari M; Reardon D; Brickelmeier M; Goelz SE; Benjamin CD
J Interferon Cytokine Res; 1995 Jan; 15(1):55-61. PubMed ID: 7544230
[TBL] [Abstract][Full Text] [Related]
13. Human interferon-alpha receptor: identification of the region involved in binding to interferon-alpha B.
Hirata MH; Sackett D; Hirata RD; Nguyen NY
J Interferon Cytokine Res; 1996 Oct; 16(10):845-52. PubMed ID: 8910770
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against IFN gamma-binding proteins recognize a member of IFN alpha R complex.
Bello I; Rodes L; Saura PL
Biochem Biophys Res Commun; 2001 Feb; 280(4):1197-202. PubMed ID: 11162654
[TBL] [Abstract][Full Text] [Related]
15. Identification of a linear epitope of interferon-alpha2b recognized by neutralizing monoclonal antibodies.
Blank VC; Sterin-Prync A; Retegui L; Vidal A; Criscuolo M; Roguin LP
Eur J Biochem; 1999 Oct; 265(1):11-9. PubMed ID: 10491153
[TBL] [Abstract][Full Text] [Related]
16. Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons.
Adolf GR
J Gen Virol; 1987 Jun; 68 ( Pt 6)():1669-76. PubMed ID: 2438379
[TBL] [Abstract][Full Text] [Related]
17. Analysis of antigenic domains on natural and recombinant human IFN-beta by the inhibition of biologic activities with monoclonal antibodies.
Redlich PN; Grossberg SE
J Immunol; 1989 Sep; 143(6):1887-93. PubMed ID: 2476486
[TBL] [Abstract][Full Text] [Related]
18. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
Ghislain J; Lingwood CA; Fish EN
J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
[TBL] [Abstract][Full Text] [Related]
19. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
20. Identification of critical residues in bovine IFNAR-1 responsible for interferon binding.
Cutrone EC; Langer JA
J Biol Chem; 2001 May; 276(20):17140-8. PubMed ID: 11278538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
